Geron reported $8.52M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Amgen USD 694M 29M Jun/2025
Bio Techne USD 2.01M 141K Mar/2025
Cassava Sciences 2.6M 301K Sep/2024
Cytokinetics USD 24.26M 1.32M Jun/2025
Exelixis 23.4M 3.9M Sep/2023
Genmab DKK 9M 4M Jun/2025
Geron USD 8.52M 233K Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
Incyte USD 594K 66K Jun/2025
MacroGenics USD 802K 826K Jun/2025
Novartis USD 289M 19M Jun/2025